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ABSTRACT 
Background:  Orthodontic tooth movement is a complex process involving a number of 
inflammatory and anabolic/catabolic pathways.  Further, successful treatment depends on 
proper timing of orthodontic measures with regard to patient’s growth spurt.  Saliva 
analysis has emerged as a non-invasive collection method to track biomarkers relevant to 
both tooth movement biology and growth prediction.  The aim of the present study was to 
analyze changes in tooth movement and assess relationships with salivary levels of 
alkaline phosphatase, IGF-1, TGF-β1, testosterone, BMP-2, BMP-4, and BMP-9t.   
Methods: Twenty seven healthy patients (17 females, 10 males) with a mean age of 13.3 
years, undergoing orthodontic treatment with a non-extraction treatment plan were 
selected for the study.  Height, weight, and other demographic features were recorded; 
maxillary and mandibular alginate impressions were obtained, and 10 mL saliva samples 
were taken at the initial visit (T0), after 4 weeks (T1), 3 months (T2), and then at 3-month 
intervals (T3, T4, T5).  Casts were made from alginate impressions. Little’s Irregularity 
Index, intercanine widths, intermolar widths, arch lengths, and tooth widths were 
measured.  Saliva samples were analyzed for the concentrations of alkaline phosphatase, 
		 v 
IGF-1, TGF-β1, testosterone, BMP-2, BMP-4, and BMP-9 by multiplex immunoassay 
and/or ELISA.  Data were analyzed using correlation coefficients and ANOVA.   
Results: Over the six timepoints, there were statistically significant changes in the level 
of testosterone (p < 0.05) and Little’s Irregularity Index (p < 0.01), with the most 
significant changes occurring at the beginning of treatment (T0 to T1).  Statistically 
significant correlations (p < 0.05) were observed between testosterone and height/weight, 
intercanine width and intermolar width, BMP-4 and intercanine/intermolar width, 
alkaline phosphatase and testosterone, alkaline phosphatase and TGF-β1, and among the 
BMPs. 
Conclusion: The changes in Little’s Irregularity Index reflects successful progress of the 
orthodontic treatment.  The correlations observed among the various salivary 
concentrations suggest a number of further directions for study.  
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BACKGROUND AND LITERATURE REVIEW 
 
Biological Foundations of Tooth Movement 
Tooth movement induced by orthodontic forces is a complex process involving bone 
remodeling.  The most widely accepted model for the biology of tooth movement is the 
pressure-tension theory1.  The foundation of the pressure-tension theory was laid 
primarily by Sandstedt, Oppenheim, and Schwarz2.  When a tooth is subjected to a 
continuous force, the opposing sides of the surrounding periodontal ligament (PDL) 
undergo distinct changes: on the leading or “pressure” side, bone is resorbed, while on 
the trailing or “tension” side, new bone is formed3.  Since Sandstedt’s work in 1904, 
other theories have been suggested as alternatives or supplements to the pressure-tension 
theory, specifically the hydrostatic theory and bone-bending theory.  Despite the number 
of theories, the consensus is that tooth movement is likely a product of multiple 
biological pathways acting simultaneously.  
  
Histological observations indicate that tooth movement occurs in multiple phases4.  
Application of a loading force leads to initial tooth movement until compression on the 
leading side of the tooth reduces localized blood flow, leading to necrosis and the 
creation of a cell-free area termed a hyalinization zone.  Further tooth movement cannot 
occur until the hyalinized tissue is destroyed and cells re-populate the space.  After cells 
migrate to the zone, tooth movement resumes, with direct resorption of bone along the 
pressure side and bone deposition on the tension side.  Burstone classified this process 
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into three phases: an initial phase of tooth movement lasting 1-2 days, a lag phase of 4-20 
days, and a post-lag phase of increasing tooth movement after hyalinized tissue has been 
removed5.  
 
Molecular regulation of the processes of tooth movement is complex and a large number 
of signaling molecules have been implicated6.  Of particular interest are the processes 
involving the regulation of osteoclastic and osteoblastic activities.  Osteoclasts are 
multinucleated cells derived from fusion of macrophages7.  Osteoclast differentiation and 
activation are thought to be regulated by cytokines (extracellular signaling proteins), 
particularly the receptor activator of nuclear factor kappa-b (RANK) system8.   There are 
3 key elements to the RANK system: the receptor (RANK), the ligand (RANKL) and the 
inhibitor osteoprotegerin (OPG).  RANKL production is up-regulated in response to 
orthodontic forces and RANKL binding to RANK is critical for osteoclast activation9.  
OPG acts as a competitive inhibitor of RANKL; the RANKL/OPG ratio is important for 
maintaining a balance to the level of osteoclastic activity.  Salivary levels of soluble 
RANKL and OPG have been measured in an attempt to identify the different phases of 
tooth movement10.  Roberts et al found that the bone resorption by osteoclasts is the rate-
limiting step in tooth movement11.  
 
Osteoblast activity is regulated by a number of signaling molecules, including various 
bone morphogenetic proteins (BMPs), and transforming growth factor-beta (TGF-β)12.  
Osteoblasts are derived from mesenchymal stem cells (MSCs); the fact that MSCs can 
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differentiate into numerous tissue types such as adipose and bone explains some of the 
intricacy and redundancy of the factors involved in osteoblast differentiation13.  
 
Orthodontic measurements 
Dental cast measurement is an important tool for orthodontic record keeping and tracking 
of treatment outcomes.  A variety of different measurement techniques and standards 
have been used to assess changes due to treatment, including Little’s Irregularity Index, 
intercanine and intermolar width, and space analysis14.   
 
Little’s Irregularity Index. Little’s Irregularity Index (LII) is a scoring method devised by 
Little in 1975 to provide a quantitative method for evaluation of incisor crowding15.    LII 
has been used as an indicator of crowding in studies measuring the comparative success 
of various orthodontic treatments as well as post-treatment relapse16,17.  LII can be a less 
time-consuming method for estimating crowding relative to some systems for measuring 
arch length discrepancy, making it an attractive tool for larger scale epidemiological 
studies18. 
 
Intercanine/intermolar width. Intercanine width (ICW) can be measured as the distance 
between cusp tips or the gingival margins or the canines, while intermolar width can be 
measured between mesiolingual or distolingual cusps, or at the gingival level19.  
Reliability studies have shown that ICW and IMW measurements are highly reproducible 
and clinically acceptable20.  Digital analysis of casts indicate a strong correlation between 
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ICW measurements and arch length, while only a weak correlation exists between IMW 
and arch length21.  ICW and IMW measurements exhibit statistically significant gender-
based differences, making them a potentially useful tool in sex determination in the field 
of forensics22. However, other studies have shown that related metrics, such as 
mandibular canine index (the ratio of mesiodistal dimensions of lower canines to the 
ICW) do not show statistically significant gender differences.  This contradiction may be 
due to differences in the observed populations among the various studies, as well as the 
way that the ratio is calculated23.    In an orthodontic context, ICW and IMW are used to 
track whether variations in treatment (for example, extraction vs. non-extraction) result in 
differences in arch form24,25. 
 
Space Analysis. Space analysis can be defined as the discrepancy between the space 
needed for the properly aligned teeth and the space available in the dental arch, and 
therefore serves as a measure of dental crowding26,27.     
 
Salivary biomarkers of growth and tooth movement 
In recent years, salivary diagnostic tools have emerged that provide a noninvasive 
alternative to drawing blood28.  The applications of saliva-based diagnostics include the 
diagnosis of endocrine and immune disorders, identification of infectious agents, 
screening for cancer, and evaluation of psychiatric issues such as anxiety and stress29,30.   
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In addition to predicting disease states, salivary diagnostics allow for the measurement of 
hormones and other factors that play key roles in growth and dental development.  These 
factors include: 
 
Insulin-like growth factor-I (IGF-1). IGF-1 has been shown to play important roles in 
development. Along with growth hormone (GH), IGF-1 regulates the pubertal growth 
spurt31.  Circulating levels of IGF-1 promote bone growth and bone density32.  IGF-1 has 
also been shown to stimulate growth of the mandibular condyle in rats33,34.  Salivary 
levels of IGF-1 can be measured, but accuracy may be an issue due to low levels relative 
to the level of serum IGF-135. In contrast, IGF-1 levels measured by blood spot have been 
shown to be reliable36.  In 1985, Massoud et al used blood spot analysis showed that IGF-
1 levels in rabbits increase progressively through puberty, then fall to pre-puberty 
levels37.  Blood spot analysis has also been used to establish ranges for both males and 
females through age 18: mean IGF-1 levels peak at age 13 in females, and age 15 in 
males38.  IGF-1 levels have been shown to correlate positively with maturation stages 
determined by hand-wrist radiographic analysis and with changes in mandibular length39.  
Jain et al found statistically significant differences in serum levels of IGF-1 between 
cervical maturation stages CS-4 and CS-5, and suggested a minimum serum level of 310 
ng/mL as a key factor in whether orthodontic treatment should be considered40.  In 2015, 
Masoud et al concluded that longitudinal changes in IGF-1 levels correlate with vertical 
facial growth41.  However, the authors found no significant relationship between single 
(non-longitudinal) IGF-1 measurements and facial growth.  The authors reasoned that 
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individual measurements are uninformative, given that low IGF-1 could indicate both 
pre- and post-pubescent state.  In addition to its use as a marker of maturation, IGF-1 
levels may change in response to orthodontic treatment. IGF-1, in concert with GH, may 
play a role in regulating root resorption: rats given subcutaneous injections of 
recombinant GH showed an increase in IGF-1 levels in cells and a corresponding 
decrease in indexes of root resorption42.  Several studies have suggested IGF-1 plays a 
role in repair during tooth movement43; recently, Proff et al showed an up-regulation in 
the IGF-1 genes of PDL cells in response to a mechanical stressor44. 
 
Testosterone. Testosterone has been shown to promote growth by stimulating GH 
secretion both directly and through its aromatization to estrogen45.  Evidence from GH-
deficient patients suggests that testosterone can independently trigger a substantial 
pubertal growth spurt46.  This direct mechanism is supported by the presence of androgen 
receptors in hypertrophic chondrocytes and bone cells at sites of endochondral 
ossification47.  Testosterone affects both cell differentiation (through an IGF-mediated 
process) and cell proliferation48.  Salivary testosterone levels have been shown to be 
highly correlated with free testosterone levels in blood, and have been used in studies 
across a spectrum of disciplines, from development to athletic performance to 
psychology49,50,51.  In relation to oral biology, testosterone has been implicated in a 
number of roles.  For instance, rats deficient in testosterone were found to have increased 
rates of tooth movement and reduced resorption52.  Steffens et al found an association 
between high levels of serum testosterone and increased prevalence and severity of 
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periodontitis, although the mechanism by which testosterone mediates periodontitis is 
unclear53.   Testosterone has also been administered to improve orthodontic outcomes: 
Birlik et al increased the rate of bone formation in the mid-palatal suture of rats for rapid 
maxillary expansion54.     
 
Transforming growth factor-beta. The transforming growth factor-beta superfamily of 
signaling proteins includes TGF-βs and bone morphogenetic proteins (BMPs)55.  These 
proteins play various roles in growth regulation and development.  For example, TGF-β3 
is necessary for proper secondary palate fusion, while BMPs and related growth and 
differentiation factors (GDFs) regulate the development of skeletal structures56,57.  TGF-β 
consists of three isoforms (β1, β2, β3) and has been detected in the saliva58.  The TGF- β1 
isoform is important in all stages of skeletal development and bone growth, with the most 
widely accepted view that TGF- β1 act by stimulating proliferation and differentiation of 
osteoblasts while inhibiting osteoclast activity59.  However, other studies have suggested 
that TGF-β1 plays a role in increasing osteoclast activity and bone resorption60.   Karst et 
al attribute the dual nature of TGF-β1 to a concentration-dependent mechanism: low 
levels of TGF-β1 stimulate osteoclast differentiation by maintaining a high RANKL/OPG 
ratio, while high levels repress differentiation through several pathways61.  Studies of 
tooth movement further illustrate the complex role of TGF-β1, with one study finding 
similar expression of TGF-β1 at both the compression and tension sides of teeth 
subjected to rapid maxillary expansion, and another study finding a higher concentration 
at the compression site, supporting TGF-β1’s role in bone resorption62,63.     
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BMPs. Bone morphogenetic proteins are a subset of the TGF-β superfamily. BMPs play 
essential roles in osteoblast differentiation through Smad-mediated signaling64.  Members 
of the BMP family exhibit similar yet distinct functions.  For example, BMP-7 plays an 
important role in skeletal patterning and cartilage growth, while BMP-2 is critical for 
postnatal regeneration of bone65,66,67.  The role of BMPs in tooth movement was explored 
by Mitsui et al, who showed an increase in BMP-2 expression and concurrent decrease in 
BMP antagonists when human osteoblastic cells were subjected to a compressive force, 
with 1.0 g/cm2 as  the optimal loading68.   
  
Alkaline Phosphatase. Alkaline phosphatase has been observed to play a role in 
mineralization as early as 192469.  Specifically, tissue-nonspecific alkaline phosphatase is 
thought to promote mineral formation by hydrolyzing pyrophosphate to inorganic 
phosphate70.  Alkaline phosphatase has been found in gingival crevicular fluid (GCF), 
with higher levels indicative of inflammation related to gingivitis and periodontitis71.  
Alkaline phosphatase levels in GCF have also been identified as a tool for measuring the 
extent of bone modeling due to orthodontic tooth movement72,73,74.   In addition, Perinetti 
et al found a significant relationship between GCF alkaline phosphatase activity and 
CVM stages, with peaks levels occurring during the CS3 and CS4 stages of maturation75.  
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HYPOTHESIS  
 Null	Hypothesis	(H0):	There	is	no	correlation	between	orthodontically-induced	tooth	movement	and	salivary	levels	of	the	biomarkers	alkaline phosphatase, IGF-1, 
TGF-β1, testosterone, BMP-2, BMP-4, and BMP-9.   
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MATERIALS AND METHODS 
 
Subject Selection 
 
Thirty-nine subjects were enrolled in the study, all orthodontic patients at the Boston 
University, Henry M. Goldman School of Dental Medicine, Department of Orthodontics 
and Dentofacial Orthopedics.  Seven patients were terminated from the study for various 
reasons, and five patients had incomplete sample collections, leaving a total of twenty-
seven subjects with complete data sets for all timepoints. 
The inclusion criteria were: 
! Males and females 
! Ages 11 to 20 
! Seeking orthodontic treatment 
! Parents of minor patient willing to consent 
! Patient under 18 years of age willing to assent, verbally if 11 years of age, or on 
the informed consent form if between the ages of 12 and 17 
! English speaking 
! Patient between the ages of 18 and 20 willing to consent for themselves 
! A non-extraction orthodontic treatment plan 
The exclusion criteria were: 
! Any medical condition that could affect growth (i.e. acromegaly, dwarfism, hyper 
or hypothyroidism, achondroplasia, etc.) as noted in their medical history 
	11		
 
! Any significant unstable health issue or condition per medical history review (i.e. 
cancer, hepatitis, TB, etc.) 
! Any use of medication or condition that could affect saliva production (i.e. Ca 
channel blockers, beta-blockers, anti-depressants, etc.) 
! Active orthodontic treatment 
! Current smoking or tobacco use, which could alter tooth movement 
! Chronic use of NSAID (more than three times per week), which could alter tooth 
movement 
! Orthodontic treatment plan involving surgical correction 
! Orthodontic treatment plan involving removable aligners for dental correction 
The IRB – Institutional Review Board – of Boston University reviewed and approved the 
consent forms and study protocol.  The consent forms for the study were comprised of 
two consent forms and two assent forms as follows:    
! Consent form for subjects between the age of 18 and 20 years old 
! Consent form for parents of subjects under the age of 18 
! Assent form for subjects ages 12 through 17 years old 
! Assent form for subjects 11 years old 
Patients and parents were consented at the treatment planning orthodontic appointment.  
During this visit, the study was explained to potential subjects and parents if under the 
age of 18.  The consent forms, the background and rationale for the study, the number of 
visits, the samples being collected and the procedures for such collections were explained 
in detail.  It was explained to subject and parents that their participation was strictly 
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voluntary and that their participation in the study would not interfere with their 
orthodontic care.  Subjects were encouraged to ask questions during this process.  
Subjects who desired to participate in the study, signed the appropriate consent forms, 
after which their medical history was reviewed and initial samples collected.  There was 
no group assignment, no randomization, and no use of control subjects 
 
 
Data Collection 
 
Participating subjects had sample collection performed at six different time points 
designated as T0 through T5 over the course of approximately twelve months.  All data 
collection was performed during the patient’s regular orthodontic treatment for the 
convenience of the patient – saving them from unnecessary appointments.  T0 sample 
collection was recorded at the treatment planning orthodontic visit.  T1 was collected four 
weeks after orthodontic appliances and initial wire were placed – initial wire being a 
0.016 Nickel-Titanium, or a multi-stranded stainless steel wire.  T1 represents the initial 
phase of tooth movement.  The third time point collected during a regular orthodontic 
visit was T2 – this was performed at least two months after T1.  T3, T4, and T5 sample 
collections were collected consecutively at intervals of approximately three months.  The 
following data was collected at time point T0: 
! Age, gender, height (in centimeters, cm), weight (in kilograms, kgs) 
! 10 mL sample of saliva, collected in a FalconTM 50 mL tube 
! Upper and lower alginate impressions using Dentsply Jeltrate Plus Fast Set and 
PVS bite registration using Dentsply Regisil Super Fast Set 
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The following data was collected at each time point from T1 through T5: 
! Height (in centimeters, cm), weight (in kilograms, kgs) 
! 10 mL sample of saliva, collected in a FalconTM 50 mL tube 
! Upper and lower alginate impressions using Dentsply Jeltrate Plus Fast Set and 
PVS bite registration using Dentsply Regisil Super Fast Set 
All subjects were de-identified and assigned a unique code – the data was organized in 
Excel spreadsheets and kept in a special drive accessible only by the orthodontic 
department.  Each salivary sample and dental cast were labeled with the same unique 
subject code as well as the time point at which it was collected, i.e. LC22 T1, LC34 T0.    
 
Height and Weight measurements 
 
Height and weight was recorded at each visit T0 through T5 using a Detecto Scale Weigh 
Beam Eye-Level analog physician’s scale.  Height was recorded in centimeters and 
weight was recorded in kilograms.  All measurements were recorded in an Excel 
spreadsheet.   
 
Cast/tooth measurements 
The tooth movement was measured on all casts, from the six time points - T0 through T5.  
All casts were poured in Type 3 dental stone for durability.  The casts of twenty-seven 
subjects at the six different time points were used to measure Little’s Irregularity index , 
intercanine width, intermolar width, and space analysis7,87.  All measurements were taken 
by the same investigator (A.C.S.) using a digital caliper (Machine DRO 200mm digital 
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caliper with fine pointed jaws, ME-CAL-FP-200).  All measurements were recorded on 
an Excel spreadsheet.  Little’s Irregularity Index (LII) was used to quantify the 
mandibular anterior alignment from cuspid to cuspid.  This involves measuring the linear 
displacement between adjacent teeth at their contact points.  A total of five measurements 
between the mesial of the mandibular cuspids were recorded and summed, yielding the 
irregularity index.  The mandibular intercanine width (ICW) was measured from cusp tip 
to cusp tip and recorded in millimeters.  The mandibular intermolar width (IMW) was 
measured from the cusp tip of the mesiobuccal cusp to the cusp tip of the mesiobuccal 
cusp of the permanent first molars and recorded in millimeters.  The space analysis was 
conducted using the methodology described by Bishara et al90.  The space analysis was 
computed by dividing and measuring the mandibular cast into four straight line segments 
as follows:  mesial of lower left mandibular first molar to mesial of lower left canine, 
mesial of lower left canine to mesial of lower left central, mesial of lower left central to 
mesial of lower right canine, mesial of lower right canine to mesial of lower right 
mandibular first molar.  The mesiodistal width of each individual tooth from the lower 
left 2nd premolar to the lower right 2nd premolar were then measured and totaled.  The 
sum of the tooth widths was then subtracted from the sum of the four arch segments.  A 
positive difference represents spacing in the arch, a negative difference represents 
crowding in the arch.  	
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Saliva collection 
Each subject was asked to rinse with water before collection.  The patient was given a 
FalconTM 50 mL tube and was asked to let the saliva pool in their mouth and occasionally 
tip their head forward and allow the saliva to drool into the tube.  The subject was 
encouraged not to spit forcefully into the tube to prevent bubbles in the sample.  If the 
subject was having difficult time producing saliva, they were given one or two small 
squares of odorless, tasteless, semi-transparent, moisture-resistant paraffin wax film 
(Parafilm M®) to chew on to help stimulating salivary secretion.  The saliva samples 
were then stored at -80oC. 
 
Saliva Sample Analysis 
The number of saliva samples analyzed was one hundred and sixty-two (twenty-seven 
subjects with six collection time points each, T0 through T5).  The samples were labeled 
with the de-identified subject number and the respective time point.  Salivary samples 
were transported to the Forsyth Institute (Cambridge, Massachusetts) from Boston 
University Henry M. Goldman School of Dental Medicine (Boston, Massachusetts) in an 
insulated styrofoam cooler packed with dry ice (-78.5oC).  Once samples arrived at 
Forsyth Institute, they were transferred to ice and organized by subject ID.  Samples were 
thawed on ice (approx. 3 hours), vortexed 10 seconds each, and then centrifuged for 12 
minutes at 1,500 g, at 4°C.  Supernatants were aliquoted into four 1.5 mL sterile, labeled 
Eppendorf tubes per sample. Any remaining supernatant was distributed between the 4 
tubes.  All supernatant aliquots were re-frozen at -80°C. Assays performed at The Forsyth 
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Institute included:  IGF-1, Testosterone, TGF-β1, BMP2, BMP4, BMP9, and Alkaline 
Phosphatase.  Each assay had its own individual kit as follows: 
1. R&D Systems (Minneapolis, MN), Quantikine ELISA Human IGF-1, cat# DG100; 
Sensitivity:  range 0.007-0.056 ng/mL, mean 0.026 ng/mL 
2. R&D Systems (Minneapolis, MN), Parameter Testosterone assay, cat# KGE010; 
Sensitivity:  range 0.012-0.041 ng/mL, mean 0.030 ng/mL 
3. R&D Systems (Minneapolis, MN), TGF-β1 Luminex kit, cat# LTGM100; 
Sensitivity:  range 2.1-24.6 pg/mL, mean 11.1 pg/mL 
4. R&D Systems (Minneapolis, MN), Screening Luminex panel (BMP-2, -4, -9) cat# 
LXSAHM-3; Sensitivity:  BMP-2, 3.6 pg/mL; BMP-4, 5.0 pg/mL; BMP-9, 0.6 
pg/mL 
5. Abcam (Cambridge, MA) Colorimetric Alkaline Phosphatase Assay, cat# ab83369; 
Sensitivity:  >10 µU 
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Instrumentation  
Assays 3 and 4 above (TGF-β1 and BMP panel) were read on the Bio-Plex 200 
instrument using Bio-Plex Manager version 6.0 software.  Raw data included a graph of 
the standard curve of each analyte and the following: 
Table 1: Data collected on salivary samples 
Abbreviation Description 
Type Standard (S), Blank (B), Unknown (X) 
Well Well location on 96-well plate. 
FI Mean fluorescence intensity of analyte. 
Obs Conc Observed concentration of analyte, calculated from its FI 
(fluorescence intensity) and the standard curve. Note that obs. 
conc of standards are back-calculated from their FI and standard 
curve. 
Std Dev Standard deviation of a replicate group of wells. 
Obs Conc %CV Observed concentration of analyte with coefficient of variation 
of a replicate group of wells.  
Exp Conc Expected concentration (of standards). 
Obs/Exp*100 Recovery rate for the observed vs. expected concentration of 
standards or controls. 
 
Bio-Rad Classification/Verification kits are used on a weekly basis to verify quality 
control and classification parameters.  Preventive maintenance of the instrument is 
performed on a yearly basis by Bio-Rad field specialists.  In order to prevent cross-
contamination between plates, a wash and sanitize step is performed between each plate. 
Sonication of the instrument’s probe is also performed between plates.  
 
Assays 1, 2 and 5 above (IGF-1, Testosterone, Alkaline Phosphatase), were read on a 
SpectraMax 340PC spectrophotometer using SOFTmax Pro version 4.3 software. Quality 
control and calibration of the instrument are performed every six months. Generated 
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results are interpreted in the SOFTmax Pro software before being exported as an excel 
file.  Raw data for the cytokine analysis were analyzed to optimize the standard curves 
using Bio-Plex Manager v6.0 software. Assays run on the SpectraMax were optimized 
for standard curves using the SOFTmax Pro v4.3 software. Only preliminary 
optimization of standard curves will be performed.  All data were exported as Microsoft 
Excel files and saved in the following format: “BUortho_assay_date.xls”  
The plate maps are as follows:  
Figure 1: Assay plate map 
 1 2 3 4 5 6 7 8 9 10 11 12 
A S1 S1 B          
B S2 S2 B          
C S3 S3           
D S4 S4           
E S5 S5           
F S6 S6           
G S7 S7           
H S8 S8           
 
Assays were carried out per manufacturer instructions (for detailed assay protocols, see 
Appendix). 
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STATISTICS 
  
Standard descriptive statistics including averages and standard deviations were computed 
for each salivary marker and cast measurement, at each time point T0 through T5.  
Changes in variables over time were evaluated using repeated measures ANOVA.  Intra-
examiner reliability was assessed using intraclass correlation tests using a mixed-effect, 
single measure model91.   Statistical significance was determined by using an alpha level 
of 0.05.   
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RESULTS 
Descriptive Statistics 
 
Summary statistics for the sample studied are reported in Table 2. 
 
 
Table 2: Descriptive Statistics 
 N Age (Mean) Age (S.D.) 
Females 17 13.06 1.85 
Males 10 13.60 1.96 
Total 27 13.26 1.87 
 
 
The age range for study patients was 11 to 17.  Height and weight were recorded at each 
time point for each patient.  Summary statistics are shown in Tables 3 and 4. 
 
Table 3: Mean Heights of Study Patients at each Timepoint (cm) 
 T0 T1 T2 T3 T4 T5 
Females 157.00 157.88 158.88 159.41 160.00 160.12 
Males 171.30 172.00 172.40 173.50 174.30 175.10 
Total 162.30 163.11 163.89 164.63 165.30 165.67 
 
Table 4: Mean Weights of Study Patients at each Timepoint (kgs) 
 T0 T1 T2 T3 T4 T5 
Females 53.15 53.66 54.54 54.99 56.19 56.38 
Males 70.58 70.17 70.67 72.57 74.80 75.89 
Total 59.61 59.77 60.51 61.50 63.08 63.60 
 
Over the course of the study, the average height for males increased by 2.2% and the 
average weight increased by 7.5%.  Similar results were observed for females (height 
increase of 2% and weight increase of 6.1%).   A statistically significant (p < 0.01), 
moderate, negative correlation was observed between age and the percent change in 
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height (r=-0.54) and weight (r=-0.59) between T0 and T5. 		The	relationships	between	age	and	changes	in	height	and	weight	are	shown	in	Figure	2	and	3.		Age	of	subjects	was	not	strongly	correlated	with	either	height	or	weight	changes	over	the	course	of	the	study.	
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Figure 2: Changes in subject weight vs. age 
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Figure 3: Changes in subject height vs. age  
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Dental Cast Measurement Data 
 
The mean and standard deviation for Little’s Irregularity Index (LII), intercanine width 
(ICW), intermolar width (IMW) and space analysis (SA) are summarized in Table 5 and 
Figures 4-7. 
 
Table 5: Mean and standard deviation of cast metrics (mm) 
 T0 T1 T2 T3 T4 T5 
 Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
LII   3.00 2.09 1.65 1.73 0.86 1.11 0.58 0.69 0.42 0.44 0.41 0.49 
ICW 27.04 3.34 27.16 3.12 27.46 2.88 27.24 2.48 26.92 2.07 26.79 1.97 
IMW 45.23 3.66 44.97 3.51 45.62 3.43 45.60 3.22 45.47 3.11 45.18 3.21 
SA 2.69 3.83 3.13 3.62 3.36 3.04 2.58 2.40 2.47 1.47 2.25 1.92 
 
Results of ANOVA analysis show that changes in LII were statistically significant (p < 
0.01), while the changes over time in ICW, IMW and SA were not statistically 
significant. For LII, pairwise comparisons using ANOVA showed significant differences 
(p < 0.05) between T0 and T1 with all other time points.  Differences in LII between T2 
and T5 were not statistically significant.  Pairwise comparisons of the various time points 
for ICW, IMW, and SA failed to yield any significant variation.  SA values for 21 of 27 
patients were greater than zero at T0, reflecting the low frequency of crowding cases in 
the study.  SA values correlated significantly with arch length measurements (r = 0.55, p 
< 0.01) but no significant correlation was observed between tooth measurements and SA.   
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To assess the reliability and reproducibility of dental cast measurements, casts for three 
patients (six casts each) were re-measured by the same examiner (ACS).  Intraclass 
correlation coefficients for each category of measurement are listed in Table 6. 
 
Table 6: Intra-examiner reliability measured by ICC 
Measurements Intraclass Correlation Coefficient 
Arch Segment 0.9985 
Tooth Size 0.9517 
LII 0.8531 
ICW 0.9393 
IMW 0.9189 
 
 
Intra-examiner reliability was shown to be high for measurement types with the exception 
of LII, which was above the commonly accepted benchmark of 0.75 for clinical utility. 
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Figure 4: Mean value of Little’s Irregularity Index at each timepoint 
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Figure 5: Mean value of intercanine width at each timepoint 
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Figure 6: Mean value of intermolar width at each timepoint 
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Figure 7: Mean value of space analysis at each timepoint 
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Salivary Biomarker Data 
The various antibody kits used to quantify salivary markers required minimum levels of 
the biomarker in order for a measurement to be made.  The percentage of samples that 
met this requirement are shown in Table 7. 
 
Table 7: Percentage of samples meeting minimum biomarker sensitivity 
 T0 T1 T2 T3 T4 T5 
ALP 100% 100% 100% 100% 100% 100% 
IGF-1 40% 48% 50% 41% 33% 30% 
Testosterone 100% 100% 100% 100% 100% 100% 
TGF-β1 92% 100% 100% 100% 100% 100% 
BMP-2 100% 100% 100% 96% 93% 96% 
BMP-4 20% 20% 19% 26% 26% 15% 
BMP-9 72% 88% 85% 78% 85% 81% 
 
 
IGF-1 and BMP-4 were the least successfully measured biomarkers, with only 40% and 
21% of samples meeting the sensitivity requirements, respectively.  The mean values and 
standard deviations for each biomarker at each time point are shown in Table 8. 
 
Table 8: Mean and standard deviation of biomarkers at each timepoint 
 T0 T1 T2 T3 T4 T5 
 Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. Mean S.D. 
ALP   0.66 0.46 0.80 0.51 0.67 0.53 0.63 0.54 0.62 0.51 0.62 0.64 
IGF-1  105.82 131.37 77.38 109.96 114.12 142.35 88.66 102.10 257.78 600.67 300.47 660.82 
Testosterone 557.60 373.49 607.29 509.83 677.91 522.18 736.75 529.31 763.08 597.43 849.22 770.68 
TGF-β1 93.44 35.41 110.96 43.71 144.83 121.54 119.55 88.98 127.18 103.57 139.85 112.76 
BMP-2 25.55 20.48 20.79 8.53 23.84 16.23 23.36 15.84 19.70 9.34 18.35 11.72 
BMP-4 25.58 17.05 27.82 23.31 39.58 51.70 39.32 52.32 66.64 43.15 30.95 42.28 
BMP-9 1.40 1.55 1.77 3.52 2.13 5.85 2.37 5.99 1.58 3.79 1.45 3.48 
*ALP in units of U/mL, all others in units of pg/mL 
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Changes in biomarker measurements by gender are shown in Figures 8-14.  Of the T0 to 
T5 time series for each biomarker, only testosterone showed statistically significant 
variation (p = 0.046, power = 0.708).  Pairwise comparisons between time points for 
testosterone showed highest significance was observed between T0 and subsequent time 
points.   
 
 
 
 
	  
	32		
 
Figure 8: Mean value of alkaline phosphatase at each timepoint 
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Figure 9: Mean value of IGF-1 at each timepoint 
 
 
 
 
 
 
 
 
 
 
 
 
 	
 -    
 100.00  
 200.00  
 300.00  
 400.00  
 500.00  
 600.00  
 700.00  
 800.00  
 900.00  
0 1 2 3 4 5 
M
ea
n 
IG
F-
1 
C
on
ce
nt
ra
tio
n 
(p
g/
m
L)
 
Timepoints 
IGF-1 Males 
Females 
Total 
	34		
 
	
Figure 10: Mean value of testosterone at each timepoint 
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Figure 11: Mean value of TGF-	β1 at each timepoint 
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Figure 12: Mean value of BMP-2 at each timepoint 
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Figure 13: Mean value of BMP-4 at each timepoint 
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Figure 14: Mean value of BMP-9 at each timepoint 
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Correlations between independent variables 
The correlations among the various dental cast measurements and salivary biomarkers 
were calculated. The resulting correlation matrix is shown in Table 9.  
 
Table 9: Correlation between measured variables 
 Ht. Wt. LII ICW IMW SA ALP IGF-1 Test. TGFβ1 BMP-2 BMP-4 BMP-9 
Ht. - 0.66* -0.09 0.32* 0.46* -0.06 -0.14 -0.15 0.71* 0.06 -0.06 -0.60* -0.16 
Wt.  - -0.22* 0.46* 0.55* 0.21* 0.10 -0.14 0.49* 0.04 0.05 -0.66* -0.19* 
LII   - -0.10 -0.14 -0.27* -0.07 -0.14 -0.01 -0.09 -0.03 -0.09 -0.02 
ICW    - 0.76* 0.49* -0.04 -0.15 0.22* 0.16* 0.01 -0.51* -0.13 
IMW     - 0.36* 0.01 -0.18 0.42* 0.19* -0.00 -0.52* -0.14 
SA      - 0.23* -0.05 -0.11 0.14 0.03 -0.17 -0.08 
ALP       - 0.04 -0.18* 0.33* -0.03 -0.28 -0.05 
IGF-1        - -0.19 -0.01 -0.09 0.09 0.03 
Test.         - 0.16 -0.06 -0.40* -0.10 
TGFβ1          - -0.15 -0.31 -0.03 
BMP-2           - 0.73* 0.70* 
BMP-4            - 0.94* 
BMP-9             - 
 * Correlation is significant at the 0.05 level (2-tailed) 
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DISCUSSION  
This study tracked several types of data over the course of orthodontic treatment for 27 
subjects: biometric (height/weight), clinical (LII, ICW, IMW, and space analysis 
measurements from casts) and biological (salivary concentrations of ALP, IGF-1, TGF-
β1, testosterone, BMP-2, BMP-4 and BMP-9).  This combination of traditional 
orthodontic analytical tools with the comparatively new field of salivary diagnostics has 
the potential to provide new insights into the biology of tooth movement.  The findings of 
the present study support the use of these new tools and suggest directions for future 
research. 
 
Of the series of measurements taken on each dental cast, LII was found to exhibit 
significant changes over the course of the study.  For all 27 patients examined, LII 
decreased between T0 and T5, indicating the success of orthodontic treatment in reducing 
mandibular anterior crowding.  Improvement in crowding as measured by LII at each 
timepoint is shown in Table 10. 
 
Table 10: Distribution of subjects by degree of crowding 
# of subjects with: T0 T1 T2 T3 T4 T5 
Minor crowding (LII < 3) 17 21 25 26 27 27 
Moderate crowding  (3 < LII < 6) 7 5 2 1 0 0 
Severe crowding (LII > 6) 3 1 0 0 0 0 
*Classifications based on Little irregularity scatter diagram15 
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The predominance of minor crowding among patients is partly a consequence of the 
enrollment criteria: patients who were likely candidates for extraction were excluded. In 
addition, patients that began as non-extraction treatment but later required extractions 
were also excluded.  
 
The Pearson correlation coefficients and intraclass correlation coefficients (ICC) were 
calculated to evaluate intra-examiner reliability.  Strong correlations (>0.90) were 
observed for all measurements with the exception of LII,  which at an ICC = 0.8531 was 
still above the benchmark of 0.75 for “good” reliability100.  This result is consistent with 
other research that showed relatively poor reproducibility of the contact point 
displacement measurements used to calculate LII101. 
 
Cumulative measurements of tooth size and arch lengths were found to be highly 
correlated.  A correlation of 0.55 was found between arch length measurements and the 
calculated value for crowding/spacing, while no correlation was observed between tooth 
size and crowding/spacing.  This observation is consistent with studies that found no 
significant relationship between tooth size and crowding, as well as studies indicating 
that arch length is a strong predictor of degree of crowding102,103.  However, similar 
studies have reached conflicting conclusions, suggesting a complex relationship between 
tooth width, arch length, and crowding104.    
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The inclusion criteria of the study also played some role in the correlations observed: 
only non-extraction cases were considered, so no teeth were removed and therefore the 
sum of the tooth widths would remain constant.  A possible exception would be if 
interproximal reduction was used, but this study did not look at the different treatment 
mechanic/modalities among the sample.  However, evidence of interproximal reduction 
was visually observed on 2-3 patients, but was not taken into consideration.  
 
This study illustrates the potential for salivary analysis in reflecting orthodontic tooth 
movement.  Moderate correlations were observed between ICW/IMW and the biomarkers 
testosterone, TGF-β1, and BMP-4.  While these results suggest a relationship between 
orthodontic treatment and biomarkers, confounding factors make it difficult to interpret 
these results.  For example, ICW was found to correlate weakly with testosterone levels, 
but this may be due to males in general having both larger ICW and higher testosterone 
than females105. The weak negative correlation observed between BMP-4 concentration 
and ICW/IMW (r = -0.51, p <= 0.01) was not expected, as BMP-4 is thought to assist in 
the process of osteoblast differentiation106.  Wescott et al found that BMP-4 gene 
expression was down-regulated in human PDL cells subjected to tensile strain, but were 
unsure how to interpret the functional significance of this finding107.   
 
A number of correlations were observed among the various salivary makers.  The 
strongest correlations were observed among the BMPs.  This finding is consistent with 
the synergistic effects that the various BMPs are thought to have with each other108.  A 
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weak negative correlation was also observed between ALP and testosterone.  This 
relationship is consistent with that observed by Steffens et al, who found that in an 
inflammatory environment, high testosterone levels were associated with decreased ALP 
levels109.  Steffens proposed that testosterone acts as an immunosuppressant, dampening 
the inflammatory response to bone remodeling.  Seifi et al showed that in castrated rats 
with orthodontic appliances, tooth movement was increased relative to non-castrated rats 
with normal testosterone levels52.  Similarly, the results of the present study may reflect 
the impact of testosterone on localized inflammation during orthodontic movement110.  
This linkage would also explain the negative correlation observed between testosterone 
levels and BMP-4.  Finally, a positive correlation was observed between ALP and TGF-
β1.  As discussed previously, TGF-β can promote either osteoblastic or osteoclastic 
activity, depending on the TGF-β concentration61.  The positive correlation with ALP 
suggests that TGF-β1 is promoting osteoblast differentiation at the concentrations found 
in our saliva samples.  
 
In terms of study limitations, the high number of out-of-range salivary concentrations 
was a considerable issue, particularly for IGF-1 and BMP-4.  The incompleteness of the 
data could result from issues with saliva sample handling and storage.  For example, 
Antonelli et al found that saliva specimens stored at 4o C or 25oC for 24 hours had 
significantly reduced levels of free IGF-1 relative to specimens stored immediately at -
80o C111.  Further, they found that samples retested after 9 months showed 28% of 
original IGF-1 levels unless a preservative solution had been initially added to the 
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sample.  These findings may have implications for the present study, as sample collection 
was done in a clinical setting after which samples were transported to the research 
laboratory.  In addition, samples were tested at the end of the longitudinal study period, 
and early samples may have partially degraded due to re-testing and the 
thawing/refreezing steps involved in that process; IGF-1 levels in later samples (T4, T5) 
were on average three times higher than earlier samples (Table 8).  Similar issues with 
sample handling may have affected BMP-4 levels, although no literature was found 
regarding BMP-4 in saliva.    
 
The correlations observed are likely due to a variety of causes not fully measured or 
covered by the data collected.  In particular, changes in salivary biomarkers are due to 
some combination of physiological maturation (systemic factors) and orthodontic 
treatment (local factors), but it is difficult to isolate the impact of each.  Future studies 
should include a control group of similar age, race, and gender mix to the treatment 
group, but who are not undergoing orthodontic treatment.  Salivary measurements of this 
control group would provide a baseline that may make it easier to observe changes in 
biomarkers resulting from the orthodontic treatment.  
 
In addition, salivary flow rates vary within and between subjects, and flow rate 
differences can affect biomarker levels, especially those at low concentrations112.  
Specifically, some studies have shown that females have lower whole saliva flow rates 
and decreased protein content relative to males113,114. The current study only tracked 10 
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male and 17 female subjects; future studies should explore the impact of gender on 
biomarker and orthodontic movement correlations by increasing sample size to allow for 
higher power analysis within genders.    
 
Advances in technology have led to increased scanning of casts into 3-dimensional 
models that can be used with software for measuring the relevant parameters. Early 
studies showed that manual measurement provided better accuracy and reproducibility 
but, with computer methods and technology becoming more sophisticated, digital models 
can now offer similar reliability and reproducibility to manual measurements of plaster 
casts115,116,117,118.  In some cases, particularly with LII, the use of digital models has been 
shown to provide superior reproducibility to digital calipers119.  Future investigation of 
the hypotheses of the present study could incorporate computer-aided analysis of dental 
measurements to automate the process and potentially allow for a larger scale study.   
  
	46		
 
CONCLUSIONS 
The study used multiple observation methods in a longitudinal and cross-sectional 
analysis of patients undergoing orthodontic treatment: biometric data collection, dental 
cast measurements, and salivary concentration analysis.  Statistically significant changes 
over time were observed for Little’s Irregularity Index, with the largest changes occurring 
between T0 and T1, and T1 and T2.  We also observed significant longitudinal changes 
in testosterone, with most of the increase driven by the male subjects.  A number of 
correlations among the various measurements were observed.  Among salivary 
concentrations, the three BMPs measured were highly positively correlated.  We also 
observed a negative correlation between alkaline phosphatase and testosterone, while 
alkaline phosphatase was positively correlated with TGF- β1. 
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APPENDIX 
Assay Protocols 
 
1. R&D Systems (Minneapolis, MN) Quantikine ELISA Human IGF-1, cat#DG100. 
Remove kit from 4°C and allow components to warm to RT (room temperature), 
EXCEPT conjugate which should remain on ice.  
 
Prepare reagents: 
1. Wash buffer: Add 20 mL concentrate to 480 mL distilled water. 
2. Substrate solution: Color reagents A and B should be mixed together in equal 
volumes within 15 minutes of use. Protect from light. 200 µL per well.  
3. IGF-1 standard: Reconstitute standard with distilled water (according to vial 
label). Produces stock of 60 ng/mL. Leave at RT for 15minutes.  
4. Label tubes S1-S8. 
5. Standard curve serial dilution: Add 360 µL calibrator diluent RD5-22 into S1 
tube. Add 200 µL RD5-22 into S2-S8. Add 40 µL stock solution to S1, mix. Add 
200 µL S1 to S2, mix. Add 200 µL S2 to S3, mix. Continue to S7. S8 is RD5-22 
only for blank.  
6. Standards are: 6000 pg/mL; 3000 pg/mL; 1500 pg/mL; 750 pg/mL; 375 pg/mL; 
188 pg/mL; 94 pg/mL; 47 pg/mL; 0pg/mL 
Assay procedure: 
1. Remove excess microplate strips from plate and return to foil pouch for later use.  
2. Add 150 µLassay diluent RD1-53 to each well. 
3. Add 50 µL standards and samples to appropriate wells. Incubate 2 hours at 4°C.  
4. Aspirate all wells. Wash 4 x 400 µL wash buffer.  
5. Add 200 µL cold IGF-1 conjugate to each well. Cover and incubate for 1 hour at 
4°C.  
6. Wash 4 x 400 µL wash buffer 
7. Add 200 µL substrate solution to each well. Incubate for 30 minutes at RT. 
Protect from light.  
8. Add 50 µL Stop solution to each well. Color will change from blue to yellow.  
9. Read within 30 minutes at 450 nm with wavelength correction at 540 nm.  
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2. R&D Systems, Parameter Testosterone assay, cat# KGE010 
Bring all reagents to room temperature before use. 
 
Prepare reagents: 
1. Wash buffer: Add 20 mL concentrate to 480 mL distilled water. 
2. Substrate solution: Color reagents A and B should be mixed together in equal 
volumes within 15 minutes of use. Protect from light. 200 µL per well.  
3. Testosterone Std: Reconstitute with 1 mL deionized water to produce a 100 
ng/mL stock. Mix completely and let stand for 15 min with gentle agitation.  
4. Label tubes S1-S8. 
5. Standard curve serial dilution: Add 900 µL calibrator diluent RD5-48 into S1 
tube. Add 200 µL RD5-48 into S2-S8. Add 100 µL stock solution to S1, mix. Add 
400 µL S1 to S2, mix. Add 200 µL S2 to S3, mix. Continue to S7. S8 is RD5-22 
only for blank.  
6. Standards are: 10,000 pg/mL; 3,333 pg/mL; 1,111 pg/mL; 370 pg/mL; 123 
pg/mL; 41 pg/mL; 13.7 pg/mL; 4.5 pg/mL; 0pg/mL 
Assay procedure: 
1. Remove excess microplate strips from plate and return to foil pouch for later use.  
2. Add 50 µL Primary antibody solution to each well, excluding the non-specific 
binding wells.  All wells except NSB should be blue now. 
3. Incubate for 1 hour at RT on shaker.  
4. Wash 4 x 300 µL wash buffer 
5. Add 100 µL Calibrator diluent RD5-48 to NSB wells and to Blank wells. 
6. Add 100 µL standard and samples 
7. Add 50 µL Testosterone Conjugate to all wells.  
8. Incubate 3 hours at RT on shaker 
9. Wash 4 x 400 µL wash buffer 
10. Add 200 µL substrate solution to each well. Incubate for 30 minutes at RT. 
Protect from light.  
11. Add 50 µL Stop solution to each well. Color will change from blue to yellow.  
12. Read within 30 minutes at 450 nm with wavelength correction at 540 nm.  
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3. R&D Systems, TGF-1 Luminex kit, cat# LTGM00 
 
Activation/Neutralization of samples: 
1. Prepare 1N HCl: slowly add 8.33 mL 12N HCl to 91.67 mL deionized water. Mix 
well 
2. Prepare 1.2N NaOH/0.5M HEPES: slowly add 12 mL 10N NaOH to 75 mL 
deionized water. Mix well. Add 11.9g HEPES. Mix well and bring final volume 
to 100 mL with deionized water.  
3. Add 20 µL1N HCl to 100 µL of sample. Mix well and incubate for 10 min at RT 
4. Add 20 µL 1.2N NaOH/0.5M HEPES. Mix well.  
Reagent preparation: 
1. Wash buffer: Add 20 mL concentrate to 480 mL distilled water. 
2. Reconstitute std cocktail with RD5-49 (1 mL) allow to sit for 15 min at RT. 
3. Label tubes S1-S8. 
4. Standard curve serial dilution: Add 500 µL stock cocktail to S1. Add 200 µL 
calibrator diluent RD5-49 into S2-S8. Add 100 µL S1 to S2, mix. Add 100 µL S2 
to S3, mix. Continue to S7.  
5. Diluted microparticle preparation: vortex each bead vial for 1 min. Combine 50 
µL bead concentrate with 5 mL bead diluent. Protect from light. Vortex 1 min 
before adding to plate.  
6. Diluted biotin antibody cocktail preparation: Add 50 µL antibody concentrate to 
biotin antibody diluent. Mix well.  
7. Streptavidin-PE preparation: Combine 55 µL strep-PE concentrate with 5.5 mL 
wash buffer. Mix well. 
Assay Procedure: 
1. Bring all reagents to RT before use.  
2. Prepare all reagents, working standards, and samples as directed.  
3. Add 50 µL standard or sample per well. 
4. Add 50 µL beads per well.  
5. Incubate 2 hours at RT on shaker 
6. Wash 3 x 100 µL wash buffer 
7. Add 50 µL biotin antibody cocktail to each well 
8. Incubate 1 hour at RT on shaker 
9. Wash 3 x 100 µL wash buffer 
10. Add 50 µL Strep-PE to each well 
11. Incubate 30 min at RT on shaker 
12. Wash 3 x 100 µL wash buffer 
13. Resuspend beads in 100 µL sheath fluid and incubate for 5 min on shaker.  
14. Read on Luminex 200.  
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4. R&D Systems, Screening Luminex panel (BMP-2, -4, -9) 
 
Reagent preparation: 
1. Wash buffer: Add 20 mL concentrate to 480 mL distilled water. 
2. Reconstitute std cocktail with RD6-52 (250 µL) allow to sit for 15min at RT. 
3. In tube labeled S1: Add 900 µL RD6-52 to 100 µL stock standard produce 1X 
standard. 
4. Label tubes S2-S8. 
5. Standard curve serial dilution: Add 200 µL calibrator diluent RD6-52 into S2-S8. 
Add 100 µL S1 to S2, mix. Add 100 µL S2 to S3, mix. Continue to S7.  
6. Diluted microparticle preparation: vortex each bead vial for 1 min. Combine 500 
µL bead concentrate with 5 mL bead diluent. Protect from light. Vortex 1 min 
before adding to plate.  
7. Diluted biotin antibody cocktail preparation: Add 500 µL antibody concentrate to 
biotin antibody diluent. Mix well.  
8. Streptavidin-PE preparation: Combine 220 µL strep-PE concentrate with 5.35 mL 
wash buffer. Mix well. 
Assay Procedure: 
1. Bring all reagents to RT before use.  
2. Prepare all reagents, working standards, and samples as directed.  
3. Add 50 µL standard or sample per well. 
4. Add 50 µL beads per well.  
5. Incubate 2 hours at RT on shaker 
6. Wash 3 x 100 µL wash buffer 
7. Add 50 µL biotin antibody cocktail to each well 
8. Incubate 1 hour at RT on shaker 
9. Wash 3 x 100 µL wash buffer 
10. Add 50 µL Strep-PE to each well 
11. Incubate 30 min at RT on shaker 
12. Wash 3 x 100 µL wash buffer 
13. Resuspend beads in 100 µL sheath fluid and incubate for 5 min on shaker.  
14. Read on Luminex 200.  
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5. Abcam (Cambridge, MA) Alkaline Phosphatase Assay kit (colorimetric) cat#ab83369 
Remove from -20oC and bring to RT. Keep samples, ALP enzyme and pNPP solution on 
ice during the assay.  
Prepare reagents: 
1. pNPP solution: dissolve 1 tablet of pNPP in 2.7 mL assay buffer to make a 5mM 
working solution. (Never touch tablets with bare hands). This is stable on ice for 
12 hours. 
2. ALP enzyme: reconstitute ALP enzyme with 1 mL assay buffer. Do not freeze. 
Enzymes are stable for up to 2 months at 4°C after reconstituting.  
Standard preparation: 
1. Prepare 1mM pNPP standard by diluting 40 µL 5mM pNPP in 160 µL assay 
buffer.  
2. Prepare standard curve as follows: 
 
Table 11: Standard curve for ALP assay kit 
Standard	#	 Vol.	1mM	pNPP	
(μL)	
Assay	buffer	
(μL)	
Conc.	pNPP	
(nmol/well)	
1	 0	 360	 0	
2	 6	 354	 2	
3	 12	 348	 4	
4	 24	 336	 8	
5	 36	 324	 12	
6	 48	 312	 16	
7	 60	 300	 20	
 
3. Add 120 µL standard to standard wells 
4. Add 80 µL sample to sample wells 
5. Add 80 µL assay buffer to blank wells 
6. Add 50 µL 5mM pNPP solution to sample and blank wells.  
7. Add 10 µL of ALP enzyme solution to each well of standard curve, mix well. 
8. Incubate plate for 1 hour at RT, protect from light.  
9. Stop all reactions by adding 20uL Stop Solution to each well, gently shake plate. 
10. Measure OD at 405nm.  
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